Ocata Therapeutics Inc fka OCAT

[joecarry]

Thanks Captain,

What you say makes a lot of sense. I was just wondering due to the below statements from Astellas, as it seems they want some of OCATA's team members to stay involved to meet their 2015-2017 Strategic Plan. Of course I have no more trust in OCATA's management.

"The acquisition of Ocata represents the coming together of two companies with significant accomplishments and a shared commitment to development innovative therapies that address the unmet medical needs of patients suffering from severe ophthalmic diseases. The acquisition also represents a step toward achieving Astellas' Strategic Plan 2015-2017.

Further, acquiring Ocata will enable Astellas to establish a presence in ophthalmology and a leading position in cell therapy.

"We highly value Ocata's R&D capabilities, including its world-leading researchers in cell therapy," commented Yoshihiko Hatanaka, President and CEO, Astellas. "We're confident that we will turn innovative science into value for patients through the creation of new value by combining both companies' capabilities under 'One Astellas,' where Ocata will be taking a key role in Astellas' R&D in ophthalmology and cell therapy."

http://finance.yahoo.com/news/astellas-acquire-ocata-therapeutics-030500707.html